Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • AgroTech • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) • Cloud Services (& Infrastructure) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • LegalTech • Life Science • Consumer • Pharmaceutical (& Medicine) |
Stages | Seed, Startup, Early Stage, Expansion, Later Stage, MBO/LBO, Series A, Series B |
Investing | United States • United Kingdom • Europe |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Mountain Group Partners is a Private Equity Fund headquartered at 1-3 St Colme Street, Edinburgh, EH3 6AA, United Kingdom. The firm boasts a diverse investment portfolio focusing on various sectors including BioTech, AgroTech, Business Solutions, Hardware & Manufacturing, HealthTech & Fitness, Cloud Services & Infrastructure, Medical Devices & Hospital Services, Healthcare & Wellness, LegalTech, Life Science, Consumer, and Pharmaceutical & Medicine. With expertise in both debt and equity investments, Mountain Group Partners caters to a broad spectrum of funding requirements, offering investment amounts ranging from a minimum of $100,000 to a maximum of $5,000,000. Their investment 'sweet spot' typically lies around $1,500,000. The firm is actively engaged in supporting companies at different stages of growth, from Seed and Startup phases to Early Stage, Expansion, Later Stage, as well as Management Buyouts/Leveraged Buyouts (MBO/LBO), Series A, and Series B funding rounds. Despite being based in Edinburgh, Mountain Group Partners originally started in Nashville, Tennessee, and continues to make strategic investments across companies operating in life sciences, ag tech, diagnostics, healthcare technology, business technology, and drug development sectors. This wide range of specialties underscores their commitment to fostering innovation and progress across multiple industries, effectively contributing to the advancement of cutting-edge technologies and solutions that hold the potential to redefine markets and improve the quality of life.